Navigation Links
Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome
Date:7/8/2008

SCOTTSDALE, Ariz., July 8 /PRNewswire-FirstCall/ -- Rural/Metro Corporation (Nasdaq: RURL) issued another reminder today for current and potential holders of 5% or more of the Company's common stock in relation to its ongoing analysis of the impact of change-in-ownership rules under Section 382 of the U.S. Internal Revenue Code ("Section 382").

In general, Section 382 limits the use of a corporation's net operating losses and certain other tax benefits following a change in ownership of the corporation. Section 382 rules governing when a change in ownership occurs are complex and subject to interpretation; however, a change in ownership generally occurs when there has been a cumulative change in the stock ownership of the corporation held by 5% stockholders of more than 50 percentage points over an applicable three-year period.

To the extent the Company has not experienced a change in ownership, subsequent changes in the stock ownership of the Company could result in a change in ownership that would trigger the limitations of Section 382. If the Company were to experience a change in ownership under Section 382, the Company may be limited in its ability to fully utilize its net operating loss tax assets to offset future taxable income.

The Company recognizes that investment decisions are within the discretion of each investor; however, along with the other risk factors set forth in the Company's most recent Form 10-K and other public filings, the Company advises investors to consider the potential negative impact of Section 382 on the Company that can arise from any of the following trading transactions (either alone or in combination):

-- Any transfer of common stock by a 5% stockholder.

-- Any transfer
'/>"/>

SOURCE Rural/Metro Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rural/Metro Announces Results for Fiscal 2008 Second Quarter
2. Rural/Metro to Host Conference Call to Discuss Fiscal 2008 Second Quarter Results
3. Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year
4. Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End
5. Rural/Metro Enters Into Amendment and Waiver to Its Senior Credit Facility; Provides Restatement Details
6. Rural/Metro Board of Directors Meets With Accipiter Capital Management
7. Political borders, health-care issues complicate pandemic planning
8. Anthem Blue Cross and Blue Shield Issues Community Report for 2007
9. National Council on Disability to Hold Quarterly Board Meeting in Seattle to Learn Issues Affecting People with Disabilities in Pacific Northwest
10. Robbins & Myers Issues Corrected Conference Call Information
11. SectorWatch.biz Issues MarketStats on Medical Products and Device Companies INCC, CMED, WX, MR and AOB
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Las Colinas FREE Community Health Fair Benefiting the Shoh-Sohail Family of Irving 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 2Health News:Top Latin American Television Companies Commit to Addressing AIDS 3Health News:Top Latin American Television Companies Commit to Addressing AIDS 4Health News:Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK 2Health News:Companion Global Healthcare Expands Service to Include Hospitals in Mexico 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 2Health News:LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 2Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 3Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 4Health News:Edge Health Solutions Selects Allscripts Electronic Health Record for Apple Mac OS X Medical Platform 5
Breaking Medicine Technology:Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 1Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 2Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 4Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 5Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 6Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 7Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 8Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 9Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 10Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 11Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 12Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 13Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 14Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 15Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 16Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 17Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 18Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 19Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 20Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 21Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 22Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 1PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 3